Erinn Downs‐Kelly

5.0k citations

94 papers · 3.5k indexed · 1 hit paper · h-index 32

Impact in

Rheumatology top 1%
- Musculoskeletal synovial abnormalities and treatments
- Bone Tumor Diagnosis and Treatments
- Soft tissue tumor case studies
Cancer Research top 2%
- Breast Cancer Treatment Studies

Papers in

Microbiology 2
Oncology 37
- HER2/EGFR in Cancer Research 14

Co-authors: John R. Goldblum Brian P. Rubin Raymond R. Tubbs Marek Skacel Christopher L. Corless Subbaya Subramanian Torsten O. Nielsen Matt van de Rijn
Journals: The American Journal of Surgical Pathology (10 papers)Archives of Pathology & Laboratory Medicine (7 papers)Modern Pathology (6 papers)Journal of Clinical Oncology (4 papers)The Breast Journal (3 papers)
Partner nations: United States Canada Australia

In The Last Decade

Erinn Downs‐Kelly

94 papers receiving 3.4k citations

Hit Papers

align trajectories log scale

Human breast microbiome correlates with prognostic features and immunological signatures in breast cancer 2021 · 199 citations

Peers

Countries citing papers authored by Erinn Downs‐Kelly

Since Specialization

Citations

This map shows the geographic impact of Erinn Downs‐Kelly's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Erinn Downs‐Kelly with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Erinn Downs‐Kelly more than expected).

Fields of papers citing papers by Erinn Downs‐Kelly

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Erinn Downs‐Kelly. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Erinn Downs‐Kelly. The network helps show where Erinn Downs‐Kelly may publish in the future.

Co-authors

The 25 scholars most cited alongside Erinn Downs‐Kelly, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Erinn Downs‐Kelly Line = papers co-authored together Erinn Downs‐Kelly links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Outcomes of ipsilateral breast tumor recurrence after breast conserving surgery: Repeat lumpectomy as an alternative to salvage mastectomy Surgery ·Philipp Harbecke, Chirag Shah, Erinn Downs‐Kelly, F. Picolli, Stephanie A. Valente, Chao Tu, Zahraa Al‐Hilli	2021	5
2	Human breast microbiome correlates with prognostic features and immunological signatures in breast cancer Genome Medicine ·Alice Tzeng, Naseer Sangwan, Liangchao Jiang, Chin-Chih Liu, Karen S. Keslar, Erinn Downs‐Kelly, Robert L. Fairchild, Zahraa Al‐Hilli, Stephen R. Grobmyer, Charis Eng Hit paper breakdown →	2021	199
3	Mammary Extranodal Rosai-Dorfman Disease With and Without Associated Axillary Lymphadenopathy: Insights for Practitioners of Breast Pathology International Journal of Surgical Pathology ·Leo Dean Williams, Nidhi Sharma, Christine N. Booth, H. Ibrahim, Erinn Downs‐Kelly, Jesse K. McKenney, Charles D. Sturgis	2020	5
4	Cystic neutrophilic granulomatous mastitis: The Cleveland Clinic experience with diagnosis and management The Breast Journal ·Michal Sygmunt, Diane M. Radford, Christopher Kovacs, Benjamin C. Calhoun, Gary W. Procop, Laura B. Shepardson, Andrea E. Dawson, Erinn Downs‐Kelly, Mary Nathisiya B, Zahraa Al‐Hilli, Alicia Fanning, Donald A. Wilson, Charles D. Sturgis	2018	37
5	Secretory breast carcinoma in an 8-year-old girl: A case report and literature review The Breast Journal ·Saud Ahmed Malik, Kristofor A. Olson, Erinn Downs‐Kelly, Brian T. Bucher, Cindy Matsen	2018	11
6	Impact of an alternative chromosome 17 probe and the 2013 American Society of Clinical Oncology and College of American Pathologists guidelines on fluorescence in situ hybridization for the determination of HER2 gene amplification in breast cancer Cancer ·Gaynell M. Fuchs, Shashirekha Shetty, Zhen Wang, Muhammed Shukri, Bryce P. Portier, G. Thomas Budd, Erinn Downs‐Kelly, Christopher Lanigan, Benjamin C. Calhoun	2017	23
7	HER2 immunohistochemical and fluorescence in situ hybridization discordances in invasive breast carcinoma with micropapillary features Modern Pathology ·Rachel L. Stewart, Sunil Thimmaiah, Evin Gulbahce, Rachel E. Factor, Katherine B. Geiersbach, Erinn Downs‐Kelly	2017	21
8	Intramucosal lipomas of the colon implicate Cowden syndrome Modern Pathology ·Jesús Villandangos, Wendy Kohlmann, Kajsa E. Affolter, Erinn Downs‐Kelly, Priyanka Kanth, Mary P. Bronner	2017	23
9	Primary Cystic Pleuropulmonary Synovial Sarcoma Presenting as Recurrent Pneumothorax Case Reports in Oncology ·Eric D. Johnson, Erinn Downs‐Kelly, David A. Bull, H. Evin Gulbahce	2017	5
10	A Clinicopathologic Evaluation of Incidental Fundic Gland Polyps With Dysplasia: Implications for Clinical Management The American Journal of Gastroenterology ·ZhaoYang XIA, Wendy Kohlmann, Keith M. Gligorich, Arkady Vladimirovich LEMOV, Elaine Lyon, Erinn Downs‐Kelly, Wade S. Samowitz, Mary P. Bronner	2017	13
11	Expression of the MHC Class II Pathway in Triple-Negative Breast Cancer Tumor Cells Is Associated with a Good Prognosis and Infiltrating Lymphocytes Cancer Immunology Research ·Andres Forero, Yufeng Li, Dongquan Chen, William E. Grizzle, Bing Huang, Sadeka Shakour, Erinn Downs‐Kelly, Josue Pilco-Pezo, Christos Vaklavas, Donald J. Buchsbaum, R Myers, Albert F. LoBuglio, Katherine E. Varley	2016	124
12	Reproducibility of residual cancer burden for prognostic assessment of breast cancer after neoadjuvant chemotherapy Modern Pathology ·Florentia Peintinger, Bruno V. Sinn, Christos Hatzis, Constance T. Albarracin, Erinn Downs‐Kelly, Dwight Knight, Rebekah Gould, W. Fraser Symmans	2015	69
13	Serrated lesions of the appendix frequently harbor KRAS mutations and not BRAF mutations indicating a distinctly different serrated neoplastic pathway in the appendix Human Pathology ·Rish K. Pai, (unknown), Douglas J. Hartman, David Hernández Gonzalo, Keith Lai, Erinn Downs‐Kelly, John R. Goldblum, Xiuli Liu, Deepa T. Patil, Ana E. Bennett, Thomas Plesec, Shih–Fan Kuan, Marina N. Nikiforova, Bonnie Shadrach, Reetesh K. Pai	2013	46
14	Delay to formalin fixation ‘cold ischemia time': effect on ERBB2 detection by in-situ hybridization and immunohistochemistry Modern Pathology ·Bryce P. Portier, Zhen Wang, Erinn Downs‐Kelly, J. Jordi Rowe, Deepa T. Patil, Zhang Ping-qi, G. Thomas Budd, David G. Hicks, David L. Rimm, Raymond R. Tubbs	2012	63
15	Lynch syndrome screening in newly diagnosed colorectal cancer in general pathology practice: From the revised Bethesda guidelines to a universal approach Scandinavian Journal of Gastroenterology ·Jane Morrison, Mary P. Bronner, Brandie Heald, Erinn Downs‐Kelly, John R. Goldblum, Xiuli Liu	2011	33
16	Clinical Implications of Margin Involvement by Pleomorphic Lobular Carcinoma In Situ Archives of Pathology & Laboratory Medicine ·Erinn Downs‐Kelly, Eiichi Itagaki, George H. Perkins, Nour Sneige, Lavinia P. Middleton	2011	50
17	The Utility of Fluorescence In Situ Hybridization (FISH) in the Diagnosis of Myxoid Soft Tissue Neoplasms The American Journal of Surgical Pathology ·Erinn Downs‐Kelly, John R. Goldblum, Rajiv M. Patel, Sharon W. Weiss, Andrew L. Folpe, Fredrik Mertens, Rachel Kirkland, Raymond R. Tubbs, Marek Skacel	2008	89
18	Poor Interobserver Agreement in the Distinction of High-Grade Dysplasia and Adenocarcinoma in Pretreatment Barrett's Esophagus Biopsies The American Journal of Gastroenterology ·Erinn Downs‐Kelly, Xu Jia-Yi, Ana E. Bennett, Elias A. Castilla, Walter H. Henricks, Lynn Schoenfield, (unknown), Lisa Yerian, Treva Rice, Lisa Rybicki, Mary P. Bronner, John R. Goldblum	2008	95
19	TLE1 as a Diagnostic Immunohistochemical Marker for Synovial Sarcoma Emerging From Gene Expression Profiling Studies The American Journal of Surgical Pathology ·Jefferson Terry, Tsuyoshi Saito, Subbaya Subramanian, RD Martínez-Rojero, Cristina R. Antonescu, John R. Goldblum, Erinn Downs‐Kelly, Christopher L. Corless, Brian P. Rubin, Matt van de Rijn, Marc Ladanyi, Torsten O. Nielsen	2007	234
20	Genome-wide transcriptome analysis of nerve sheath tumors Cancer Research ·Subbaya Subramanian, Robert B. West, Torsten O. Nielsen, Brian P. Rubin, Erinn Downs‐Kelly, John R. Goldblum, Shirley Zhu, Kelli Montgomery, Pancras C.W. Hogendoorn, Christopher L. Corless, André M. Oliveira, Christopher D.�M. Fletcher, Matt van de Rijn	2006	1

About Erinn Downs‐Kelly

Erinn Downs‐Kelly is a scholar working on Microbiology, Oncology, Cancer Research, Pathology and Forensic Medicine and Rheumatology, having authored 94 papers that have together received 3.5k indexed citations. Recurring topics across this work include Sarcoma Diagnosis and Treatment (16 papers), Breast Cancer Treatment Studies (14 papers), HER2/EGFR in Cancer Research (14 papers), Monoclonal and Polyclonal Antibodies Research (12 papers), Breast Lesions and Carcinomas (9 papers), Cancer Genomics and Diagnostics (6 papers), Tumors and Oncological Cases (6 papers) and Advanced Biosensing Techniques and Applications (6 papers). The work is most often cited by research in Rheumatology (789 citations), Cancer Research (665 citations), Oncology (1.2k citations), Pulmonary and Respiratory Medicine (1.4k citations) and Pathology and Forensic Medicine (728 citations). Erinn Downs‐Kelly has collaborated with scholars based in United States, Canada and Australia. Frequent co-authors include John R. Goldblum, Brian P. Rubin, Raymond R. Tubbs, Marek Skacel, Christopher L. Corless, Subbaya Subramanian, Torsten O. Nielsen, Matt van de Rijn, Cristina R. Antonescu and David G. Hicks. Their work appears in journals such as The American Journal of Surgical Pathology, Archives of Pathology & Laboratory Medicine, Modern Pathology, Journal of Clinical Oncology and The Breast Journal.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact